| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Marshman Fund Trust II | 11% | $170,218,006 | 6,051,120 | Marshman Fund Trust II | 31 Dec 2024 | |||
| BlackRock, Inc. | 10% | -18% | $162,281,351 | -$33,731,217 | 5,768,978 | -17% | BlackRock, Inc. | 31 Mar 2025 |
| VANGUARD GROUP INC | 8.3% | $133,156,421 | 4,733,609 | The Vanguard Group | 31 Dec 2024 | |||
| FMR LLC | 6.7% | $106,022,551 | 3,846,972 | FMR LLC | 30 Sep 2025 |
As of 30 Sep 2025, 291 institutional investors reported holding 47,338,520 shares of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY). This represents 82% of the company’s total 57,417,494 outstanding shares.
The largest institutional shareholders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) together control 60% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 6,925,942 | +2.8% | 0% | $190,878,961 |
| VANGUARD GROUP INC | 8.9% | 5,097,176 | -0.27% | 0% | $140,478,171 |
| FMR LLC | 6.7% | 3,846,972 | -18% | 0.01% | $106,022,551 |
| DIMENSIONAL FUND ADVISORS LP | 2.9% | 1,691,581 | +6.9% | 0.01% | $46,620,388 |
| AMERICAN CENTURY COMPANIES INC | 2.9% | 1,669,565 | +11% | 0.02% | $46,013,211 |
| STATE STREET CORP | 2.9% | 1,653,604 | +1.5% | 0% | $45,573,326 |
| LSV ASSET MANAGEMENT | 2.8% | 1,594,893 | +7.1% | 0.1% | $43,955,000 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.3% | 1,295,381 | +43% | 0.02% | $35,700,700 |
| Valor Management LLC | 2.2% | 1,268,204 | -81% | 52% | $34,951,702 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,258,263 | +19% | 0% | $34,681,184 |
| RENAISSANCE TECHNOLOGIES LLC | 2% | 1,137,071 | +22% | 0.04% | $31,337,677 |
| MORGAN STANLEY | 1.5% | 847,895 | +12% | 0% | $23,367,997 |
| Boston Partners | 1.3% | 753,952 | +25% | 0.02% | $20,697,199 |
| GOLDMAN SACHS GROUP INC | 1.1% | 646,653 | -10% | 0% | $17,821,756 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.99% | 570,539 | -11% | 0% | $15,724,055 |
| UBS Group AG | 0.88% | 503,081 | +213% | 0% | $13,864,912 |
| venBio Partners LLC | 0.85% | 489,194 | 0% | 7.6% | $13,482,187 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.79% | 456,401 | +4.2% | 0% | $12,578,412 |
| NOMURA HOLDINGS INC | 0.76% | 437,163 | +3.4% | 0.06% | $12,048,212 |
| NORTHERN TRUST CORP | 0.75% | 432,761 | -0.27% | 0% | $11,926,893 |
| DEUTSCHE BANK AG\ | 0.74% | 425,701 | +89% | 0% | $11,732,320 |
| Invesco Ltd. | 0.7% | 403,288 | +0.58% | 0% | $11,114,618 |
| BNP PARIBAS FINANCIAL MARKETS | 0.69% | 395,144 | 0% | 0.01% | $10,890,169 |
| Pacer Advisors, Inc. | 0.63% | 362,948 | -4.5% | 0.03% | $10,002,847 |
| AQR CAPITAL MANAGEMENT LLC | 0.62% | 355,568 | +134% | 0.01% | $9,799,455 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,925,369 | $72,018,780 | +$38,452,222 | $37.42 | 24 |
| 2025 Q3 | 47,338,520 | $1,304,870,320 | -$113,256,844 | $27.56 | 291 |
| 2025 Q2 | 51,269,247 | $1,620,478,469 | +$22,306,883 | $31.60 | 276 |
| 2025 Q1 | 50,146,732 | $1,662,685,166 | -$100,697,286 | $33.19 | 266 |
| 2024 Q4 | 52,708,361 | $1,813,641,349 | +$76,207,741 | $34.41 | 244 |
| 2024 Q3 | 49,733,016 | $1,988,873,520 | -$3,857,022 | $40.00 | 231 |
| 2024 Q2 | 50,166,269 | $1,513,673,082 | +$39,722,515 | $30.17 | 218 |
| 2024 Q1 | 48,816,806 | $1,639,185,669 | +$42,716,997 | $33.58 | 207 |
| 2023 Q4 | 38,233 | $1,248,419 | +$137,404 | $32.82 | 2 |
| 2023 Q3 | 49,305,339 | $1,615,805,180 | -$87,146,053 | $32.77 | 200 |
| 2023 Q2 | 51,735,884 | $1,820,653,244 | +$16,447,201 | $35.19 | 204 |
| 2023 Q1 | 51,249,728 | $1,673,324,902 | -$29,482,520 | $32.65 | 211 |
| 2022 Q4 | 50,974,067 | $2,808,311,303 | +$33,778,388 | $55.10 | 235 |
| 2022 Q3 | 50,423,716 | $2,235,374,752 | +$101,209,739 | $44.29 | 190 |
| 2022 Q2 | 47,765,904 | $2,318,637,647 | +$88,898,293 | $48.77 | 170 |
| 2022 Q1 | 45,800,958 | $2,228,544,068 | +$78,293,806 | $48.65 | 165 |
| 2021 Q4 | 44,333,252 | $1,890,570,678 | +$100,815,509 | $42.64 | 136 |
| 2021 Q3 | 30,862,904 | $1,183,191,908 | +$115,481,866 | $38.33 | 96 |
| 2021 Q2 | 27,860,141 | $786,497,400 | -$9,318,549 | $28.23 | 78 |
| 2021 Q1 | 27,468,707 | $907,566,000 | -$18,506,330 | $33.04 | 56 |
| 2020 Q4 | 27,956,363 | $998,030,405 | -$18,654,369 | $36.15 | 59 |
| 2020 Q3 | 28,549,056 | $940,508,000 | +$940,508,485 | $33.90 | 44 |